CGM Experience, Preferences & Blood Glucose Parameters

This is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with diabetes and healthcare professionals. Patients will use Instara- 1 and will be followed up to assess device experience, glucose parameters, and diabetes-related quality of life. Healthcare professionals will evaluate device experience and preference, including comparison with FreeStyle Libre 2.

NCT Number	NCT07607015
Lead Sponsor	Getz Pharma Collaborators: Peshawar General Hospital
Conditions	Diabete Mellitus, Type2diabetes, type1diabetes, Gestational Diabetes, Pre Diabetes
Enrollment	75 participants
Start Date	2026-09-10
Primary Completion	2027-08-10 (estimated)
Study Completion	2027-08-10 (estimated)
Updated on ClinicalTrials.gov	2026-05-26